ChinaAMC CSI Biotechnology Thematic ETF (SHA:516500)
China · Delayed Price · Currency is CNY 0.6330
+0.0270 (4.46%)
Apr 1, 2026, 4:00 PM EDT
3.09% (1Y)
| Assets | 151.98M |
| Expense Ratio | 0.60% |
| PE Ratio | 29.27 |
| Dividend (ttm) | n/a |
| Dividend Yield | n/a |
| Ex-Dividend Date | n/a |
| Payout Frequency | n/a |
| Payout Ratio | n/a |
| 1-Year Return | +3.09% |
| Volume | 21,820,000 |
| Open | 0.6100 |
| Previous Close | 0.6060 |
| Day's Range | 0.6090 - 0.6340 |
| 52-Week Low | 0.5300 |
| 52-Week High | 0.7680 |
| Beta | 0.44 |
| Holdings | 52 |
| Inception Date | Mar 4, 2021 |
About 516500
516500.SS was created on 2021-03-04 by ChinaAMC. The fund's investment portfolio concentrates primarily on health care equity. Closely track underlying index,Tightly track the target and minimize the deviation
Asset Class Equity
Category Health Care
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 516500
Provider ChinaAMC
Performance
516500 had a total return of 3.09% in the past year, including dividends. Since the fund's inception, the average annual return has been -8.26%.
Top 10 Holdings
53.47% of assets| Name | Symbol | Weight |
|---|---|---|
| WuXi AppTec Co., Ltd. | 603259 | 10.20% |
| Jiangsu Hengrui Pharmaceuticals Co.,Ltd | 600276 | 9.82% |
| Shenzhen Mindray Bio-Medical Electronics Co., Ltd. | 300760 | 9.80% |
| Shanghai Fosun Pharmaceutical (Group) Co., Ltd. | 600196 | 3.76% |
| Shanghai RAAS Blood Products Co., Ltd. | 002252 | 3.76% |
| BeOne Medicines AG | 688235 | 3.46% |
| Changchun High-Tech Industry (Group) Co., Ltd. | 000661 | 3.38% |
| Pharmaron Beijing Co., Ltd. | 300759 | 3.28% |
| Hangzhou Tigermed Consulting Co., Ltd | 300347 | 3.27% |
| Gan & Lee Pharmaceuticals. | 603087 | 2.72% |